LENZ Therapeutics, Inc. financial data

Symbol
LENZ on Nasdaq
Location
Solana Beach, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 05 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1817% % 39%
Debt-to-equity 6% % -46%
Return On Equity -30% % 38%
Return On Assets -28% % 18%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 31,289,969 shares 14%
Common Stock, Shares, Outstanding 28,588,261 shares 4%
Entity Public Float $362,600,000 USD 140%
Common Stock, Value, Issued $1,000 USD
Weighted Average Number of Shares Outstanding, Basic 28,540,519 shares 5%
Weighted Average Number of Shares Outstanding, Diluted 28,540,519 shares 5%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $24,538,000 USD -44%
Operating Income (Loss) $67,900,000 USD 0.69%
Nonoperating Income (Expense) $9,518,000 USD 29%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $16,700,000 USD -63%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $58,883,000 USD 3.2%
Earnings Per Share, Basic 0 USD/shares -55%
Earnings Per Share, Diluted 0 USD/shares -55%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $25,399,000 USD -38%
Cash, Cash Equivalents, and Short-term Investments $202,200,000 USD -6.9%
Inventory, Net $949,000 USD
Assets, Current $206,997,000 USD -6.2%
Property, Plant and Equipment, Net $1,258,000 USD 238%
Operating Lease, Right-of-Use Asset $847,000 USD -45%
Other Assets, Noncurrent $1,602,000 USD 15%
Assets $210,704,000 USD -5.9%
Accounts Payable, Current $4,323,000 USD 57%
Employee-related Liabilities, Current $4,738,000 USD 116%
Accrued Liabilities, Current $11,993,000 USD 142%
Liabilities, Current $16,316,000 USD 112%
Operating Lease, Liability, Noncurrent $461,000 USD -52%
Other Liabilities, Noncurrent $0 USD -100%
Liabilities $16,777,000 USD 92%
Accumulated Other Comprehensive Income (Loss), Net of Tax $227,000 USD -57%
Retained Earnings (Accumulated Deficit) $191,245,000 USD -44%
Stockholders' Equity Attributable to Parent $193,927,000 USD -9.9%
Liabilities and Equity $210,704,000 USD -5.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $16,049,000 USD 33%
Net Cash Provided by (Used in) Financing Activities $171,268,000 USD 106%
Net Cash Provided by (Used in) Investing Activities $18,889,000 USD 4.9%
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 28,588,261 shares 4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $2,884,000 USD -98%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $25,399,000 USD -38%
Deferred Tax Assets, Valuation Allowance $53,174,000 USD 99%
Deferred Tax Assets, Gross $53,794,000 USD 101%
Operating Lease, Liability $954,000 USD -33%
Payments to Acquire Property, Plant, and Equipment $110,000 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $59,179,000 USD 1.8%
Lessee, Operating Lease, Liability, to be Paid $1,029,000 USD -36%
Property, Plant and Equipment, Gross $719,000 USD 788%
Operating Lease, Liability, Current $493,000 USD -21%
Lessee, Operating Lease, Liability, to be Paid, Year Two $511,000 USD -11%
Lessee, Operating Lease, Liability, to be Paid, Year One $157,000 USD 4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $75,000 USD -55%
Lessee, Operating Lease, Liability, to be Paid, Year Three $361,000 USD -29%
Deferred Tax Assets, Operating Loss Carryforwards $15,543,000 USD 291%
Unrecognized Tax Benefits $4,282,000 USD 119%
Lessee, Operating Lease, Liability, to be Paid, Year Four $361,000 USD -96%
Additional Paid in Capital $384,944,000 USD 11%
Depreciation, Depletion and Amortization $36,000 USD 620%
Deferred Tax Assets, Net of Valuation Allowance $620,000 USD 738%
Share-based Payment Arrangement, Expense $10,499,000 USD 100%